Related Experiment Video
Updated: May 4, 2026

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection
Published on: February 2, 2018
Secondary hemophagocytic lymphohistiocytosis possibly induced by interferon beta-1a therapy
C Cosso1, R Cosso, M A Cimmino
1Clinica Reumatologica, Dipartimento di Medicina Interna, Università di Genova. claudio.cosso86@gmail.com.
Abstract:
A 57-year old woman with a history of multiple sclerosis, treated with interferon beta-1a in the last 5 months, was referred for hyperpyrexia (>40°C) that persisted for 15 days. At admission, there was elevation of transaminases, anemia (hemoglobin 8.9 g/dL), thrombocytopenia (platelet 135,000/mm3), and hypofibrinogenemia (fibrinogen 1.26 g/L). C-reactive protein was 10.7 mg/dL, lactate dehydrogenase 1270 U/L and ferritin 2380 ng/ mL, with hepatosplenomegaly and linfoadenomegaly. Hemophagocytic lymphohistiocytosis induced by direct stimulation of macrophages by interferon (IFN) was suspected. IFN was withdrawn as only measure and onemonth later signs and symptoms disappeared, with complete normalization of laboratory examinations.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Hepatitis
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Type I Diabetes II: Pathophysiology

